This content is machine translated CLL11 study Combination of chlorambucil and CD20 antibody the new standard as early as 2014? In an interview with InFo ONCOLOGY & HEMATOLOGY, Michael Gregor, MD, of Lucerne Cantonal Hospital, talks about the CLL11 trial. It addresses the study population, the most relevant results, and…
